ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,237.72
-0.42%
Dow Jones
39,150.33
0.04%
Gold vs US Dollar
2,320.79
0.00%
Brent Oil
84.39
0.00%
Bitcoin
64,278.83
0.30%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ)

  7. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ) News

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:LGNZZ
DateTimeSourceHeadlineSymbolCompany
19/06/202402:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202402:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202402:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202402:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202402:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202402:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
18/06/202422:14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
17/06/202421:02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
13/05/202423:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
13/05/202422:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
09/05/202423:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
09/05/202423:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
08/05/202421:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/05/202421:03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/05/202412:36Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/06/202021:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
08/05/202021:29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
06/05/202021:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202000:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202000:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202000:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
24/04/202021:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
24/04/202021:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/04/202021:41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
06/04/202022:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/04/202021:19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
13/03/202022:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
27/02/202022:38Edgar (US Regulatory)Annual Report (10-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
18/02/202022:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
18/02/202022:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
 Showing the most relevant articles for your search:USOTC:LGNZZ

Your Recent History

COIN
PXBTC
TSXV
MINE
Inomin Mines
EU
XS2626254515
ABN AMRO International b...
TG
B99C
Kingdom of Belgium
NYSE
MMU
Westerm Asset Managed Mu...
NASDAQ
FHXUHX
Richard Bernstein Adviso...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved